Invention Grant
US06471965B1 Vaccine containing whole killed herpes viruses to prevent development of atherosclerotic plaque
失效
含有全杀死的疱疹病毒的疫苗以预防动脉粥样硬化斑块的发展
- Patent Title: Vaccine containing whole killed herpes viruses to prevent development of atherosclerotic plaque
- Patent Title (中): 含有全杀死的疱疹病毒的疫苗以预防动脉粥样硬化斑块的发展
-
Application No.: US08281703Application Date: 1994-07-27
-
Publication No.: US06471965B1Publication Date: 2002-10-29
- Inventor: Daniel Golubev , Alexander Chaihorsky
- Applicant: Daniel Golubev , Alexander Chaihorsky
- Main IPC: A61K3927
- IPC: A61K3927
Abstract:
A vaccine is disclosed for the prophylaxis against pathogenic development of atherosclerotic plaque in a mammalian subject susceptible thereto which consists essentially of a multiplicity of killed whole-virus strains, selected from the group consisting of: Herpes Simplex Virus 1; Herpes Simplex Virus 2; Herpes Simplex Virus 6; Human Cytomegalovirus; and Epstein-Barr Virus; in combination with a pharmaceutically acceptable inert vaccine carrier or diluent.
Information query
